Abstract
The activated partial thromboplastin time (aPTT) is currently the most common test used to measure the anticoagulation intensity of heparins and direct thrombin inhibitors (DTIs). Vitamin K antagonists variably affect aPTT reagents. Interactions between heparin and DTIs occur during concurrent therapy. Three DTIs (lepirudin, argatroban, melagatran) and one unfractionated heparin (liquemin) were added to normal plasma (NP) samples (n = 23) and to vitamin K antagonist plasma (VKAP) samples (n = 23) of patients treated with phenprocoumon. Lepirudin and argatroban were added at concentrations from 300 to 3000 ng/ml, melagatran from 30 to 1000 ng/ml, and unfractionated heparin from 0.016 to 0.48 IU/ml. Wave parameters of clotting time and aPTT ratio curves were evaluated by multivariate analysis for inhibitors, aPTT reagents and NP and VKAP samples. Normal ranges resulting from NP samples were 34.5 +/- 1.0 s with Pathromtin SL and 33.9 +/- 0.8 s with Platelin LS. Normal ranges using VKAP were 52.8 +/- 2.6 s (Pathromtin SL) and 44.2 +/- 1.1 s (Platelin LS) (P < 0.0001). Variance analysis showed that inhibitors, plasmas (NP versus VKAP) and reagents influenced the wave characteristics of aPTT (s) (P < 0.0001) and aPTT ratios (P < 0.00...Continue Reading
References
Dec 1, 1991·Thrombosis Research·B KaiserF Markwardt
Jan 1, 1991·Haemostasis·P Baumann, C C Heuck
Jan 1, 1991·Haemostasis·J W FentonJ M Maraganore
Jan 1, 1991·Haemostasis·J M WalengaJ Fareed
Aug 1, 1990·Journal of Clinical Pathology·J M ThomsonL Poller
Jul 28, 1987·Biochemistry·S R StoneJ Hofsteenge
Aug 12, 1986·Biochemistry·S R Stone, J Hofsteenge
Aug 17, 1972·The New England Journal of Medicine·D BasuJ Cade
Aug 11, 1981·Molecular and Cellular Biochemistry·B C Johnson
Jul 30, 1981·Biochemical and Biophysical Research Communications·S OkamotoY Tamao
Jan 1, 1997·Seminars in Thrombosis and Hemostasis·J HarenbergD L Heene
Jan 1, 1997·Seminars in Thrombosis and Hemostasis·M J HurstingR P Schwarz
May 30, 1998·Archives of Internal Medicine·C KearonJ S Ginsberg
Jan 8, 1999·Journal of Enzyme Inhibition·T NilssonJ Deinum
Jan 13, 1999·Circulation·A GreinacherB Pötzsch
Mar 3, 2001·Thrombosis Research·D GustafssonR Bylund
Aug 29, 2001·Pathology·B K IpH T Moriarty
Nov 7, 2002·Seminars in Thrombosis and Hemostasis·Gerd HafnerMatthias Nauck
Nov 15, 2002·Thrombosis Research·Karin WåhlanderHenry Eriksson
Dec 14, 2002·Thrombosis Research·A M H P van den BesselaarG L A Reijnierse
Oct 3, 2003·Journal of Thrombosis and Haemostasis : JTH·C W ColwellC W Francis
Oct 31, 2003·The New England Journal of Medicine·Sam SchulmanUNKNOWN THRIVE III Investigators
Dec 4, 2003·Thrombosis Research·Tivadar FenyvesiJob Harenberg
Jan 27, 2004·The Annals of Pharmacotherapy·Paul A Arpino, Robert K Hallisey
Jun 4, 2004·Thrombosis and Haemostasis·Sebastian HarderHans-Klaus Breddin